These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammation. Gribar SC; Richardson WM; Sodhi CP; Hackam DJ Mol Med; 2008; 14(9-10):645-59. PubMed ID: 18584047 [TBL] [Abstract][Full Text] [Related]
14. Role of toll-like receptors in systemic sclerosis. Ciechomska M; Cant R; Finnigan J; van Laar JM; O'Reilly S Expert Rev Mol Med; 2013 Aug; 15():e9. PubMed ID: 23985302 [TBL] [Abstract][Full Text] [Related]
15. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling. Wang S; Schmaderer C; Kiss E; Schmidt C; Bonrouhi M; Porubsky S; Gretz N; Schaefer L; Kirschning CJ; Popovic ZV; Gröne HJ Dis Model Mech; 2010; 3(1-2):92-103. PubMed ID: 20038715 [TBL] [Abstract][Full Text] [Related]
16. Endogenous toll-like receptor ligands and their biological significance. Yu L; Wang L; Chen S J Cell Mol Med; 2010 Nov; 14(11):2592-603. PubMed ID: 20629986 [TBL] [Abstract][Full Text] [Related]
17. Targeting Toll like Receptors in Cancer: Role of TLR Natural and Synthetic Modulators. Narayanankutty A; Sasidharan A; Job JT Curr Pharm Des; 2020; 26(39):5040-5053. PubMed ID: 32693759 [TBL] [Abstract][Full Text] [Related]
18. Mammalian toll-like receptors: from endogenous ligands to tissue regeneration. Zhang Z; Schluesener HJ Cell Mol Life Sci; 2006 Dec; 63(24):2901-7. PubMed ID: 17072502 [TBL] [Abstract][Full Text] [Related]